Genomic Valley Biotech Limited (BOM:539206)
27.57
-1.82 (-6.19%)
At close: Dec 5, 2025
Genomic Valley Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.07 | 0.45 | 0.06 | 0.41 | 0.03 | 0.11 | Upgrade |
Cash & Short-Term Investments | 0.07 | 0.45 | 0.06 | 0.41 | 0.03 | 0.11 | Upgrade |
Cash Growth | -98.31% | 644.62% | -85.30% | 1441.91% | -76.61% | -69.66% | Upgrade |
Accounts Receivable | 22.14 | 22.14 | 25.3 | 22.17 | - | 0.65 | Upgrade |
Other Receivables | - | - | 0.02 | 0.02 | 0.15 | 0.09 | Upgrade |
Receivables | 22.14 | 22.14 | 25.32 | 22.2 | 0.15 | 0.74 | Upgrade |
Inventory | 2.84 | 2.84 | - | - | - | - | Upgrade |
Other Current Assets | 1.12 | 0.78 | 3.72 | 3.16 | 11.19 | 0.79 | Upgrade |
Total Current Assets | 26.18 | 26.22 | 29.1 | 25.77 | 11.37 | 1.64 | Upgrade |
Property, Plant & Equipment | 0.07 | 0.09 | 0.02 | 0.03 | 17.47 | 63.34 | Upgrade |
Long-Term Investments | - | - | 0.17 | 4.35 | 4 | - | Upgrade |
Other Intangible Assets | - | - | - | - | 0.08 | 0.13 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | 0 | 0.08 | Upgrade |
Other Long-Term Assets | 0.05 | 0.05 | 14.05 | 14.05 | 5.05 | 11 | Upgrade |
Total Assets | 43.31 | 43.57 | 43.34 | 44.2 | 37.97 | 76.18 | Upgrade |
Accounts Payable | 0.04 | 0.1 | 6.02 | 6.11 | - | 0.4 | Upgrade |
Accrued Expenses | - | - | -16.75 | 1.74 | 0.25 | 0.18 | Upgrade |
Other Current Liabilities | 4.01 | 4.48 | 18.65 | 1.09 | 1.9 | 8.13 | Upgrade |
Total Current Liabilities | 4.04 | 4.58 | 7.91 | 8.93 | 2.14 | 8.71 | Upgrade |
Long-Term Debt | - | - | - | - | - | 15.47 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | 0 | 0 | - | - | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 7.05 | 7.12 | Upgrade |
Total Liabilities | 4.05 | 4.58 | 7.92 | 8.94 | 9.19 | 31.3 | Upgrade |
Common Stock | 30.55 | 30.55 | 30.55 | 30.55 | 30.55 | 30.55 | Upgrade |
Retained Earnings | - | - | 2.41 | 2.26 | -4.22 | -4.13 | Upgrade |
Comprehensive Income & Other | 8.72 | 8.44 | 2.47 | 2.47 | 2.47 | 18.47 | Upgrade |
Shareholders' Equity | 39.26 | 38.98 | 35.42 | 35.27 | 28.79 | 44.88 | Upgrade |
Total Liabilities & Equity | 43.31 | 43.57 | 43.34 | 44.2 | 37.97 | 76.18 | Upgrade |
Total Debt | - | - | - | - | - | 15.47 | Upgrade |
Net Cash (Debt) | 0.07 | 0.45 | 0.06 | 0.41 | 0.03 | -15.36 | Upgrade |
Net Cash Growth | -98.31% | 644.62% | -85.30% | 1441.91% | - | - | Upgrade |
Net Cash Per Share | 0.02 | 0.15 | 0.02 | 0.14 | 0.01 | -5.03 | Upgrade |
Filing Date Shares Outstanding | 3.11 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | Upgrade |
Total Common Shares Outstanding | 3.11 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | Upgrade |
Working Capital | 22.13 | 21.64 | 21.19 | 16.84 | 9.23 | -7.08 | Upgrade |
Book Value Per Share | 12.64 | 12.76 | 11.60 | 11.55 | 9.42 | 14.69 | Upgrade |
Tangible Book Value | 39.26 | 38.98 | 35.42 | 35.27 | 28.71 | 44.75 | Upgrade |
Tangible Book Value Per Share | 12.64 | 12.76 | 11.60 | 11.55 | 9.40 | 14.65 | Upgrade |
Land | - | - | - | - | 20.55 | 54.66 | Upgrade |
Machinery | - | - | 0.03 | 2.97 | 3.27 | 9.07 | Upgrade |
Construction In Progress | - | - | - | - | - | 4.88 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.